ClinicalTrials.Veeva

Menu

The Effect of Intermittent Fasting on Body Composition in Women With Breast Cancer (EFFECT-BC)

Duke University logo

Duke University

Status

Withdrawn

Conditions

Breast Cancer

Treatments

Behavioral: Intermittent Fasting

Study type

Interventional

Funder types

Other

Identifiers

NCT04691999
Pro00107216

Details and patient eligibility

About

The objective of this study is to evaluate intermittent fasting after the treatment of breast cancer with surgery and radiation therapy. All participants will either delay their first meal of the day or advance their last meal to achieve an approximate 16-18 hour fasting period four times per week. Over six months, the innovative protocol will 1) assess adherence, and is expected to 2) improve body composition, quality of life and inflammatory and metabolic variables linked with outcomes after breast cancer treatment. The long-term goal of this project is to incorporate this dietary strategy as a standard component of care for breast cancer patients.

Sex

Female

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast stage I-III
  • completed any chemotherapy prior to initiation of the trial (adjuvant endocrine therapy is permitted)
  • BMI > 25 kg/m2 or body fat% greater or equal to 31%
  • have a schedule amenable to nutrition and dietitian counseling described within the study protocol as determined by the treating radiation oncologist
  • have access to the internet and email with capability to join Zoom calls

Exclusion criteria

  • Metastatic breast cancer
  • Currently receiving chemotherapy
  • Uncontrolled hypertension or diabetes, defined as systolic blood pressure over 149, diastolic blood pressure over 99, or hemoglobin A1c greater than 8.9.
  • Diabetic condition requiring the usage of insulin

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

Intermittent Fasting
Experimental group
Description:
All participants will either delay their first meal of the day or advance their last meal to achieve an approximate 16-18 hour fasting period four times per week.
Treatment:
Behavioral: Intermittent Fasting

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems